Quick Answer
Core Laboratories Inc. /DE/ reported Operating Income of $56.47 million for fiscal year 2025.
Core Laboratories Inc. /DE/ Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $56.47M | -3.6% |
| 2024 | $58.56M | +7.2% |
| 2023 | $54.64M | +31.6% |
| 2022 | $41.52M | -8.3% |
| 2021 | $45.26M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.93M | +5.7% | +36.9% |
| June 30, 2025 | $15.29M | -4.5% | +246.2% |
| March 31, 2025 | $4.42M | -48.5% | -77.7% |
| September 30, 2024 | $19.80M | +35.0% | +23.7% |
| June 30, 2024 | $16.01M | -15.3% | +86.8% |
| March 31, 2024 | $8.57M | +32.2% | -41.6% |
| September 30, 2023 | $14.67M | +0.2% | -22.4% |
| June 30, 2023 | $18.91M | +62.3% | +191.7% |
- Core Laboratories Inc. /DE/ showed a decrease of -3.6% in Operating Income compared to the prior fiscal year.
- Over the 2021–2025 period, Core Laboratories Inc. /DE/’s operating income has grown by 24.8% (from $45.26 million to $56.47 million).
- The most recent figure is from Core Laboratories Inc. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: